Early Cost-Effectiveness Analysis of Using Whole-Genome Sequencing for Patients With Castration-Resistant Prostate Cancer

Authors: Fu, Jinjing ¹, Franzen, Nora ², Aas, Eline ^{3, 4}, Koen van der Mijn, J.C. ⁵, van Leeuwen, Pim J. ⁶, Retel, Valesca ^{2, 7, ∗}

Source: In Value in Health February 2025

EBCC-14 manifesto: Addressing disparities in access to innovation for patients with metastatic breast cancer across Europe

Authors: Ignatiadis, Michail, Poulakaki, Fiorita, Spanic, Tanja, Brain, Etienne, Lacombe, Denis, Sonke, Gabe S., Vincent-Salomon, Anne, Van Duijnhoven, Frederieke, Meattini, Icro, Kaidar-Person, Orit, Aftimos, Philippe, Lecouvet, Frederic, Cardoso, Fatima, Retèl, Valesca P., Cameron, David

Source: In European Journal of Cancer August 2024 207

Preferences and considerations for interval cytoreductive surgery in advanced ovarian cancer: The patient's perspective

Authors: Lof, Pien, van Soolingen, Neeltje J., Piek, Jurgen M.J., Aarts, Johanna W.M., Retèl, Valesca P., Bukman, Maarten, Smorenburg, Carolina H., van Driel, Willemien J., Amant, Frédéric, Trum, Johannes W., Lok, Christianne A.R.

Source: In Gynecologic Oncology August 2024 187:227-234

The socioeconomic impact of cancer on patients and their relatives: Organisation of European Cancer Institutes task force consensus recommendations on conceptual framework, taxonomy, and research directions

Authors: Schlander, Michael ^{*, *}, van Harten, Wim ^†, Retèl, Valesca P, Pham, Phu Duy, Vancoppenolle, Julie M, Ubels, Jasper, López, Olaya Seoane, Quirland, Camila, Maza, Felipe, Aas, Eline, Crusius, Bernd, Escobedo, Agustín, Franzen, Nora, Fuentes-Cid, Jeanette, Hernandez, Diego, Hernandez-Villafuerte, Karla, Kirac, Iva, Paty, Artus, Philip, Thierry, Smeland, Sigbjørn, Sullivan, Richard, Vanni, Elena, Varga, Sinisa, Vermeulin, Thomas, Eckford, Rachel D

Source: In The Lancet Oncology April 2024 25(4):e152-e163

Duty to recontact in genomic cancer care: A tool helping to assess the professional's responsibility

Authors: Ploem, Martine C., Giesbertz, Noor A.A., Bredenoord, Annelien L., Retèl, Valesca P., van Harten, Wim H.

Source: European journal of cancer. 186:22-26

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100194198403.0x000001&indx=1&recIds=ETOCvdc_100194198403.0x000001

A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice

Authors: Kramer, Astrid, Schuuring, Ed, Vessies, Daan C.L., van der Leest, Paul, Geerlings, Maartje J., Rozendal, Pim, Lanfermeijer, Mirthe, Linders, Theodora C., van Kempen, Léon C., Fijneman, Remond J.A., Ligtenberg, Marjolijn J.L., Meijer, Gerrit A., van den Broek, Daan, Retèl, Valesca P., Coup, Veerle M.H.

Source: Journal of molecular diagnostics. 25(1):36-45

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100178525896.0x000001&indx=1&recIds=ETOCvdc_100178525896.0x000001

Cost-Effectiveness and Budget Impact of Future Developments With Whole-Genome Sequencing for Patients With Lung Cancer

Authors: Simons, Martijn J.H.G., Uyl-de Groot, Carin A., Retèl, Valesca P., Mankor, Joanne M., Ramaekers, Bram L.T., Joore, Manuela A., van Harten, Wim H.

Source: Value in health. 26(1):71-80

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100178577926.0x000001&indx=1&recIds=ETOCvdc_100178577926.0x000001

Health state utility and health-related quality of life measures in patients with advanced ovarian cancer

Authors: van Stein, Ruby M., Hendriks, Florine J., Retèl, Valesca P., de Kroon, Cor D., Lok, Christianne A.R., Sonke, Gabe S., de Ligt, Kelly M., van Driel, Willemien J.

Source: In Gynecologic Oncology Reports December 2023 50

Active surveillance versus treatment in low-risk DCIS: Women’s preferences in the LORD-trial

Authors: Schmitz, Renée S.J.M., Engelhardt, Ellen G., Gerritsma, Miranda A., Sondermeijer, Carine M.T., Verschuur, Ellen, Houtzager, Julia, Griffioen, Rosalie, Retèl, Valesca, Bijker, Nina, Mann, Ritse M., van Duijnhoven, Frederieke, Wesseling, Jelle, Bleiker, Eveline M.A.

Source: In European Journal of Cancer October 2023 192

Targeted combination therapies in oncology: Challenging regulatory frameworks designed for monotherapies in Europe

Authors: Vancoppenolle, Julie M., Koole, Simone N., O'Mahony, James F., Franzen, Nora, Burgers, Jacobus A., Retèl, Valesca P., van Harten, Willem H.

Source: In Drug Discovery Today August 2023 28(8)

Ten-year follow-up of the observational RASTER study, prospective evaluation of the 70-gene signature in ER-positive, HER2-negative, node-negative, early breast cancer

Authors: Vliek, Sonja B., Hilbers, Florentine S., Jager, Agnes, Retèl, Valesca P., Bueno de Mesquita, Jolien M., Drukker, Caroline A., Veltkamp, Sanne C., Zeillemaker, Anneke M., Rutgers, Emiel J., van Tinteren, Harm, van Harten, Wim H., van 't Veer, Laura J., van de Vijver, Marc J., Linn, Sabine C.

Source: In European Journal of Cancer November 2022 175:169-179

Real-World Utilization of Biomarker Testing for Patients with Advanced Non–Small Cell Lung Cancer in a Tertiary Referral Center and Referring Hospitals

Authors: van de Ven, Michiel, Koffijberg, Hendrik, Retèl, Valesca, Monkhorst, Kim, Smit, Egbert, van Harten, Wim, IJzerman, Maarten

Source: In The Journal of Molecular Diagnostics April 2021 23(4):484-494

Selecting Image-Guided Surgical Technologies in Oncology: A Surgeon's Perspective

Authors: Lindenberg, Melanie, Retèl, Valesca, van Til, Janine, Kuhlmann, Koert, Ruers, Theo, van Harten, Wim

Source: In Journal of Surgical Research January 2021 257:333-343

Long-term functional outcomes after robot-assisted prostatectomy compared to laparoscopic prostatectomy: Results from a national retrospective cluster study

Authors: Lindenberg, Melanie (M.A.), Retèl, Valesca (V.P.), Kieffer, Jacobien (J.M.), Wijburg, Carl (C.), Fossion, Laurent (L.M.C.L), van der Poel, Henk (H.G.), van Harten, Wim (W.H.)

Source: European journal of surgical oncology. 47(10):2658-2666

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100138947289.0x000001&indx=1&recIds=ETOCvdc_100138947289.0x000001

Cost‐Effectiveness of Surgery Versus Organ Preservation in Advanced Laryngeal Cancer

Authors: Beck, Ann‐Jean C. C., Harten, Wim H., Brekel, Michiel W. M., Navran, Arash, Retèl, Valesca P.

Source: Laryngoscope. 131(2):E509-E517

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100114393374.0x000001&indx=1&recIds=ETOCvdc_100114393374.0x000001

Early technology assessment of using whole genome sequencing in personalized oncology

Authors: Simons, Martijn, Van De Ven, Michiel, Coupé, Veerle, Joore, Manuela, IJzerman, Maarten, Koffijberg, Erik, Frederix, Geert, Uyl - De Groot, Carin, Cuppen, Edwin, Van Harten, Wim, Retèl, Valesca

Source: Expert review of pharmacoeconomics & outcomes research. 21(3):343-351

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100121618995.0x000001&indx=1&recIds=ETOCvdc_100121618995.0x000001

Modeling Diagnostic Strategies to Manage Toxic Adverse Events following Cancer Immunotherapy

Authors: van Delft, Frederik, Muller, Mirte, Langerak, Rom, Koffijberg, Hendrik, Retèl, Valesca, van den Broek, Daan, IJzerman, Maarten

Source: Medical decision making. 41(6):694-705

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN627136752&indx=1&recIds=ETOCRN627136752

An early economic evaluation of active surveillance for low-risk ductal carcinoma in situ.

Authors: Byng, Danalyn, Schaapveld, Michael, Lips, Esther H, van Duijnhoven, Frederieke H, Wesseling, Jelle, van Harten, Wim H, Retèl, Valesca P

Source: Future Oncology; Dec2024, Vol. 20 Issue 40, p3451-3462, 12p

Relevant factors for policy concerning comprehensive genomic profiling in oncology: stakeholder perspectives.

Authors: van Schaik, Lucas Frederik, Engelhardt, Ellen Gurumay, van Harten, Wim Herbert, Retèl, Valesca Pavlawna

Source: BMC Cancer; 11/22/2024, Vol. 24 Issue 1, p1-10, 10p

Subject Terms: TECHNOLOGY assessment, MEDICAL specialties & specialists, NUCLEOTIDE sequencing, INDIVIDUALIZED medicine, THEMATIC analysis

A scenario‐drafting study to explore potential future implementation pathways of circulating tumor DNA testing in oncology.

Authors: Kramer, Astrid, Rubio‐Alarcón, Carmen, van den Broek, Daan, Vessies, Daan C. L., van't Erve, Iris, Meijer, Gerrit A., Vink, Geraldine R., Schuuring, Ed, Fijneman, Remond J. A., Coupé, Veerle M. H., Retèl, Valesca P.

Source: Molecular Oncology; Nov2024, Vol. 18 Issue 11, p2730-2742, 13p